Norbrook has announced the launch of Marbodex Aural, the most recent addition to its Otitis Management System for dogs.Norbrook has announced the launch of Marbodex Aural, the most recent addition to its Otitis Management System for dogs.

Norbrook says the ingredients in Marbodex Aural (marbofloxacin, clotrimazole, dexamethasone) are proven to relieve pain and inflammation quickly, deal with key bacterial and fungal infections effectively and thereby improve pet comfort.

The company says the inclusion of marbofloxacin makes Marbodex Aural an ideal first choice for cases of otitis externa that are:

  • Suppurative1
  • Expected to respond poorly or have responded poorly to other classes of antibiotics
  • Known to be infected with Pseudomonas spp1 

Marbodex Aural also contains clotrimazole, a broad spectrum antifungal effective against otitis caused by Malassezia pachydermatis, and dexamethasone, a fast acting steroid whose absorption is not increased in inflamed ears.

Marbodex Aural is applied once a day and has two soft nozzles to reduce pain on application and prevent cross-contamination during treatment. It can be used for extended treatment periods of seven to fourteen days  when treating persistent infections.

Marbodex Aural is available in all veterinary wholesalers now. For more information about Marbodex and to take advantage of the launch offers, contact your Norbrook Territory Manager or call 01536 741147 for more information. 

Reference:

  1. Patterson, S. 2012. Pseudomonas otitis infection. NAVC A Clinician’s Brief. Consultant on call. September. Pp 60-63 

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.